Inovio Pharmaceuticals Inc. Stock Rallies 6.9%, Outperforms Peers
Dow Jones2026/10/23 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. rallied 6.9% to $0.90 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 25,955.34 and Dow Jones Industrial Average falling 1.2% to 52,215.16.
This was the stock's second consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 67.0% short of its 52-week high of $2.72, which the company achieved on December 17th.
The stock outperformed some of its peers, as Johnson & Johnson fell 1.4% to $263.81, Statera Biopharma Inc. fell 50.0% to $0.00, and Pfizer Inc. fell 1.28% to $30.03.
Trading volume totaled 3.9 million, compared to the 50-day average of 4.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 23, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Circle issues 500 million USDC on the Solana network

Cardano vs Solana: Analysts and ADA Holders Clash Over Adoption

Ming-Chi Kuo: Google reduces next year's Broadcom-designed TPU shipments by 20% and plans to increase MediaTek's share
Renowned Apple and supply chain analyst Ming-Chi Kuo pointed out that Google has reduced the 2027 shipment volume of the TPU 8i series, designed by Broadcom, by about 1 million units, while planning to increase its procurement of the TPU 8t, designed by MediaTek. This move reflects that, limited by power and supply chain constraints, Google is prioritizing its computing resources towards the development of cutting-edge models.

